Tradename: BALFAXAR

Proper Name: prothrombin complex concentrate, human-lans

Indication: Indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for an urgent surgery/invasive procedure.                       

Approval Date: 07/21/2023

Manufacturer: Octapharma USA, Inc.


Leave a Reply

Your email address will not be published. Required fields are marked *